Cargando…

Perioperative Targeted Therapy Or Immunotherapy In Non-Small-Cell Lung Cancer

Targeted therapy and immunotherapy have changed the treatment modes for advanced non-small cell lung cancer (NSCLC), moving from second-line to first-line treatment and significantly extending patients’ survival. Surgery and chemoradiotherapy remain the main treatment options for patients with local...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sa, Huanlan, Song, Peng, Ma, Kewei, Gao, Yong, Zhang, Li, Wang, Deqiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6781597/ https://www.ncbi.nlm.nih.gov/pubmed/31632066 http://dx.doi.org/10.2147/OTT.S222412

Ejemplares similares

Progress and perspectives of perioperative immunotherapy in non-small cell lung cancer
por: Peng, Yurong, et al.
Publicado: (2023)

Corrigendum: Progress and perspectives of perioperative immunotherapy in non-small cell lung cancer
por: Peng, Yurong, et al.
Publicado: (2023)

Efficacy of Immunotherapy Combined with Antiangiogenic Therapy in Treatment-Failure Patients with Advanced Carcinoma Ex Pleomorphic Adenoma of the Submandibular Gland: A Case Report
por: Sa, Huanlan, et al.
Publicado: (2022)

Expert consensus on perioperative immunotherapy for local advanced non-small cell lung cancer
por: Qiu, Bin, et al.
Publicado: (2021)

Expert consensus on perioperative immunotherapy in non-small cell lung cancer: an editorial
por: Facchinetti, Francesco, et al.
Publicado: (2021)

Targeted therapies and immunotherapy in non-small-cell lung cancer
por: Cortinovis, D, et al.
Publicado: (2016)

Expert consensus on perioperative immunotherapy for locally advanced non-small cell lung cancer
por: Lim, Jeong Uk, et al.
Publicado: (2021)

Immunotherapy as a targeted therapy in non-small cell lung cancer
por: Rocco, Danilo, et al.
Publicado: (2019)

Clinical recommendations for perioperative immunotherapy‐induced adverse events in patients with non‐small cell lung cancer
por: Ni, Jun, et al.
Publicado: (2021)

Systematic review of the perioperative immunotherapy in patients with non-small cell lung cancer: evidence mapping and synthesis
por: Ni, Yunfeng, et al.
Publicado: (2023)

Combination of immunotherapy with targeted therapies in advanced non-small cell lung cancer (NSCLC)
por: Moya-Horno, Irene, et al.
Publicado: (2018)

Frontiers of ctDNA, targeted therapies, and immunotherapy in non-small-cell lung cancer
por: Zhu, Chennianci, et al.
Publicado: (2020)

Perioperative immunotherapy in stage IB-III non-small cell lung cancer: a critical review of its rationale and considerations
por: Sim, Jae Kyeom, et al.
Publicado: (2023)

Recent Advances in Perioperative Immunotherapies in Lung Cancer
por: Fukuda, Shota, et al.
Publicado: (2023)

Perioperative Therapy for Non-Small Cell Lung Cancer with Immune Checkpoint Inhibitors
por: Soh, Junichi, et al.
Publicado: (2021)

VEGF/VEGFR-Targeted Therapy and Immunotherapy in Non-small Cell Lung Cancer: Targeting the Tumor Microenvironment
por: Zhao, Yueshui, et al.
Publicado: (2022)

Emerging Therapies in Thoracic Malignancies—Immunotherapy, Targeted Therapy, and T-Cell Therapy in Non–Small Cell Lung Cancer
por: Sepesi, Boris, et al.
Publicado: (2020)

Small-Cell Lung Cancer—An Update on Targeted and Immunotherapies
por: McNamee, Nicholas, et al.
Publicado: (2023)

Combination strategies of immunotherapy in non-small cell lung cancer: facts and challenges
por: Li, Chu-Ling, et al.
Publicado: (2021)

NLCIPS: Non-Small Cell Lung Cancer Immunotherapy Prognosis Score
por: Song, Peng, et al.
Publicado: (2020)

Advances in Targeted Therapy and Immunotherapy for Non-small Cell Lung Cancer Based on Accurate Molecular Typing
por: Dong, Jingsi, et al.
Publicado: (2019)

The Emerging Role of Targeted Therapy and Immunotherapy in the Management of Brain Metastases in Non-Small Cell Lung Cancer
por: Wong, Annick
Publicado: (2017)

Current Landscape of Non-Small Cell Lung Cancer: Epidemiology, Histological Classification, Targeted Therapies, and Immunotherapy
por: Rodak, Olga, et al.
Publicado: (2021)

Therapeutic advances in non‐small cell lung cancer: Focus on clinical development of targeted therapy and immunotherapy
por: Cheng, Yuan, et al.
Publicado: (2021)

Immunotherapy for Non-Small Cell Lung Cancer
por: Yoon, Sung Ho
Publicado: (2014)

Perioperative chemoimmunotherapy in a patient with stage IIIB non-small cell lung cancer
por: Liang, Hengrui, et al.
Publicado: (2020)

First-Line Therapy for Metastatic Non–Small Cell Lung Cancer: State-of-the-Art Targeted Therapy and Immunotherapy Approaches
por: Bauml, Joshua, et al.
Publicado: (2020)

Biomarkers/Molecular Targets, Immunotherapy, and Treatments for Non–Small Cell Lung Cancer
por: Waxman, Elizabeth S., et al.
Publicado: (2016)

Expert consensus on perioperative treatment for non-small cell lung cancer
por: Duan, Jianchun, et al.
Publicado: (2022)

Perioperative systemic therapies for non-small-cell lung cancer: Recent advances and future perspectives
por: Lampridis, Savvas, et al.
Publicado: (2023)

Progress in immunotherapy for small cell lung cancer
por: Zhao, Dong, et al.
Publicado: (2020)

Targeted Therapy and Immunotherapy in Early-Stage Non-Small Cell Lung Cancer: Current Evidence and Ongoing Trials
por: de Scordilli, Marco, et al.
Publicado: (2022)

New Targeted Therapy for Non-Small Cell Lung Cancer
por: Chung, Eun Ki, et al.
Publicado: (2023)

Lobe‐specific analysis of perioperative chemotherapy for non‐small cell lung cancer patients
por: Lei, Xi, et al.
Publicado: (2023)

Immunotherapy and the Treatment of Non–Small Cell Lung Cancer
por: Walker, Suzanne
Publicado: (2016)

Biomarkers of immunotherapy in non-small cell lung cancer
por: Wang, Lingling, et al.
Publicado: (2020)

Comparison between immunotherapy efficacy in early non-small cell lung cancer and advanced non-small cell lung cancer: a systematic review
por: Wang, Yimin, et al.
Publicado: (2022)

Gender and outcomes in non-small cell lung cancer: an old prognostic variable comes back for targeted therapy and immunotherapy?
por: Pinto, Joseph A, et al.
Publicado: (2018)

Gamma Knife Radiosurgery for Brain Metastases in Non-Small Cell Lung Cancer Patients Treated with Immunotherapy or Targeted Therapy
por: Cho, Anna, et al.
Publicado: (2020)

Sex dimorphism in response to targeted therapy and immunotherapy in non-small cell lung cancer patients: a narrative review
por: Huang, Yingbo, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_5d4v44ak38e013rufg0qi17mdv